Argent Capital Management LLC boosted its position in shares of Addus HomeCare Corporation (NASDAQ:ADUS – Free Report) by 56.4% during the first quarter, Holdings Channel reports. The firm owned 70,235 shares of the company’s stock after buying an additional 25,315 shares during the quarter. Argent Capital Management LLC’s holdings in Addus HomeCare were worth $6,578,000 at the end of the most recent reporting period.
Several other large investors have also modified their holdings of ADUS. Bank of America Corp DE lifted its stake in Addus HomeCare by 11.3% in the 1st quarter. Bank of America Corp DE now owns 323,037 shares of the company’s stock valued at $30,252,000 after buying an additional 32,714 shares in the last quarter. Smith Group Asset Management LLC grew its stake in Addus HomeCare by 10.0% in the 1st quarter. Smith Group Asset Management LLC now owns 5,760 shares of the company’s stock worth $539,000 after acquiring an additional 525 shares during the period. Amundi raised its holdings in Addus HomeCare by 13.8% in the 1st quarter. Amundi now owns 2,868 shares of the company’s stock valued at $269,000 after acquiring an additional 347 shares during the last quarter. EverSource Wealth Advisors LLC lifted its position in Addus HomeCare by 19.1% during the first quarter. EverSource Wealth Advisors LLC now owns 1,237 shares of the company’s stock worth $116,000 after buying an additional 198 shares during the period. Finally, California State Teachers Retirement System lifted its holdings in shares of Addus HomeCare by 33.0% during the 1st quarter. California State Teachers Retirement System now owns 23,511 shares of the company’s stock worth $2,202,000 after acquiring an additional 5,835 shares during the period. 95.35% of the stock is currently owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
ADUS has been the topic of a number of research analyst reports. Citigroup reiterated a “market outperform” rating on shares of Addus HomeCare in a report on Friday, July 24th. Weiss Ratings raised Addus HomeCare from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, July 9th. Barclays upped their target price on shares of Addus HomeCare from $92.00 to $96.00 and gave the company an “underweight” rating in a research note on Wednesday, July 8th. Finally, Citizens Jmp reiterated a “market outperform” rating and issued a $142.00 price target on shares of Addus HomeCare in a research note on Monday, May 18th. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, Addus HomeCare presently has an average rating of “Moderate Buy” and an average target price of $131.50.
Addus HomeCare Trading Down 1.0%
Addus HomeCare stock opened at $115.48 on Friday. Addus HomeCare Corporation has a 1 year low of $87.95 and a 1 year high of $124.43. The firm’s 50-day moving average is $101.68 and its 200-day moving average is $101.47. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.83 and a current ratio of 1.83. The company has a market cap of $2.16 billion, a P/E ratio of 21.35, a PEG ratio of 1.60 and a beta of 0.88.
Addus HomeCare (NASDAQ:ADUS – Get Free Report) last announced its quarterly earnings data on Monday, May 4th. The company reported $1.62 earnings per share for the quarter, beating analysts’ consensus estimates of $1.52 by $0.10. The business had revenue of $363.50 million during the quarter, compared to the consensus estimate of $366.41 million. Addus HomeCare had a net margin of 6.89% and a return on equity of 9.80%. The company’s revenue for the quarter was up 7.7% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.42 EPS. On average, equities analysts expect that Addus HomeCare Corporation will post 6.24 earnings per share for the current year.
Insider Transactions at Addus HomeCare
In other news, insider Heather Brianne Dixon sold 288 shares of the business’s stock in a transaction on Monday, June 22nd. The shares were sold at an average price of $93.77, for a total transaction of $27,005.76. Following the completion of the transaction, the insider owned 44,371 shares of the company’s stock, valued at approximately $4,160,668.67. The trade was a 0.64% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 788 shares of company stock valued at $73,506 in the last quarter. Company insiders own 4.10% of the company’s stock.
About Addus HomeCare
Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.
The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.
See Also
- Five stocks we like better than Addus HomeCare
- Chevron’s Strong Quarter Shows Why It Still Leads the Energy Sector
- Amazon’s Earnings Beat Shows Why AWS Is Back at the Center of the Bull Case
- Apple’s Record Quarter Could Not Outrun Its Guidance Problem
- McKesson’s Compounding Keeps Adding Up
Want to see what other hedge funds are holding ADUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Addus HomeCare Corporation (NASDAQ:ADUS – Free Report).
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.
